These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 16213836)

  • 1. Harmonizing legal and ethical standards for interactions between health care providers and industry.
    Gunning TG; Coleman TS
    Fertil Steril; 2005 Oct; 84(4):861-6. PubMed ID: 16213836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PhRMA's Code on Interactions with Healthcare Professionals.
    Bieri D
    Am J Bioeth; 2010 Oct; 10(10):18. PubMed ID: 20945263
    [No Abstract]   [Full Text] [Related]  

  • 3. New ethical code reflects expectations for industry behavior.
    Bailey PG
    J Am Coll Radiol; 2005 Jul; 2(7):622-5. PubMed ID: 17411889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction between optometrists and industry representatives.
    Optometry; 2009 Mar; 80(3):149-53. PubMed ID: 19271358
    [No Abstract]   [Full Text] [Related]  

  • 5. Frequently asked questions regarding the revised Advanced Medical Technology Association (AdvaMed) Code of Ethics on Interactions with Health Care Professionals.
    Optometry; 2009 May; 80(5):262-6. PubMed ID: 19418651
    [No Abstract]   [Full Text] [Related]  

  • 6. Legal and ethical implications of opt-out HIV testing.
    Hanssens C
    Clin Infect Dis; 2007 Dec; 45 Suppl 4():S232-9. PubMed ID: 18190292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. From quid pro quo to quid pro bono: reshaping the influence of industry on health care epidemiologists.
    Kirkland KB
    Clin Infect Dis; 2010 Jan; 50(1):93-7. PubMed ID: 19951230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The interface between legal and ethical issues in reproductive health.
    Mann RJ
    J Midwifery Womens Health; 2004; 49(3):182-7. PubMed ID: 15134670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Punishing Health Care Providers for Treating Terrorists.
    Rubenstein LS
    Hastings Cent Rep; 2015; 45(4):13-6. PubMed ID: 26152384
    [No Abstract]   [Full Text] [Related]  

  • 10. Office of Inspector General (OIG) issues draft compliance program for pharmaceutical manufacturers.
    Turnbull GB
    Ostomy Wound Manage; 2002 Dec; 48(12):12-3. PubMed ID: 12508803
    [No Abstract]   [Full Text] [Related]  

  • 11. Paediatricians and the pharmaceutical industry: an industry perspective of the challenges ahead.
    Leather DA; Davis SC
    Paediatr Respir Rev; 2006 Mar; 7(1):60-6. PubMed ID: 16473819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The development and professionalization of health-care business consulting.
    Thompson GW
    J Med Pract Manage; 2004; 19(6):338-41. PubMed ID: 15293668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health Professionals "Make Their Choice": Pharmaceutical Industry Leaders' Understandings of Conflict of Interest.
    Grundy Q; Tierney L; Mayes C; Lipworth W
    J Bioeth Inq; 2017 Dec; 14(4):541-553. PubMed ID: 28913595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Awareness and perceptions of Vermont's prescribed product gift ban and disclosure law by prescribers and pharmacists.
    Kennedy AG; Possidente CJ; Pinckney RG
    J Pharm Pract; 2013 Feb; 26(1):36-42. PubMed ID: 22885841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmaceuticals and medical devices: business practices. End-of-year issue brief.
    Jones TM
    Issue Brief Health Policy Track Serv; 2008 Jan; ():1-32. PubMed ID: 18345554
    [No Abstract]   [Full Text] [Related]  

  • 16. Addressing gaps in health care sector legal preparedness for public health emergencies.
    Ransom MM; Goodman RA; Moulton AD
    Disaster Med Public Health Prep; 2008 Mar; 2(1):50-6. PubMed ID: 18388658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gifts to physicians from the pharmaceutical industry: an ethical analysis.
    Marco CA; Moskop JC; Solomon RC; Geiderman JM; Larkin GL
    Ann Emerg Med; 2006 Nov; 48(5):513-21. PubMed ID: 17052550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An ethical argument in support of interactions between developing world countries and pharmaceutical/biotechnology companies involved in oncology drug development.
    Markman M
    Cancer; 2008 May; 112(9):1871-3. PubMed ID: 18318430
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmaceuticals and medical devices: business practices.
    Jones TM
    Issue Brief Health Policy Track Serv; 2009 Jan; ():1-54. PubMed ID: 19297719
    [No Abstract]   [Full Text] [Related]  

  • 20. How to manage conflicts of interest with industry?
    Schowalter JE
    Int Rev Psychiatry; 2008 Apr; 20(2):127-33. PubMed ID: 18386202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.